Status:
UNKNOWN
Aricept to Improve Functional Tasks in Vascular Dementia
Lead Sponsor:
Kessler Foundation
Collaborating Sponsors:
Pfizer
Conditions:
Stroke
Vascular Dementia
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Medications for memory improvement are available but they may not actually improve the ability to do real world tasks. The purpose of this research study is to determine if a medicine used to treat me...
Detailed Description
All participants will receive a behavioral intervention as part of the testing protocol: they will be asked to generate words to complete a phrase as they read written steps to perform functional task...
Eligibility Criteria
Inclusion
- I am 18 to100 yrs old.
- I had one stroke 4 months to 5 yrs ago
- I am not taking Aricept or other cholinesterase inhibitors (e.g. Exelon, Razadyne) or memantine (Namenda).
Exclusion
- I have history of dementia and or have been diagnosed with a memory disorder prior to my stroke.
- I have been on anti-depressants or other cognitive enhancing drugs for less than 3 months and the dose is not stabilized yet.
- I consume alcohol more than or equivalent of 4 ounces hard liquor weekly.
- I am taking oral anticholinergic medications like Bethanechol, Bentyl or Detrol.
- I am a woman of childbearing potential or I am pregnant or a nursing mother.
- I have a history of chronic vomiting or diarrhea.
- I am allergic to Aricept.
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00457769
Start Date
May 1 2007
End Date
December 1 2021
Last Update
February 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kessler Foundation
West Orange, New Jersey, United States, 08902